Metabolic Research
Retatrutide
Triple-receptor agonist studied in preclinical and clinical literature for energy balance and metabolic homeostasis.
10 mg20 mg30 mg40 mg
View details →White lyophilizedHPLC + MS2–8°C
Metabolic Research
SHED
Research blend - Tirzepatide 40 mg + Retatrutide 20 mg
Research blend pairing two incretin-class analogs for parallel-pathway laboratory study.
$375TZ 40mg + RT 20mg
Select strength
Specifications
- Appearance
- White lyophilized powder
- Purity
- ≥99% by HPLC
- Identity
- Confirmed by MS
- Storage
- −20°C lyophilized · 36 months
- Reconstituted
- 2–8°C · 28 days
- Form
- Lyophilized powder
- Region
- USA
Research context
- Parallel-pathway research design
- Single-vial reconstitution
For laboratory research use only. Not for human, veterinary, diagnostic, cosmetic, or therapeutic use. Not evaluated by the FDA.
Metabolic Research
Tirzepatide
Dual-incretin analog studied in glucose homeostasis and energy-partitioning research models.
15 mg20 mg30 mg40 mg50 mg
View details →Metabolic Research
MOTS-C
A mitochondrial-derived peptide studied in metabolic homeostasis and mitochondrial-signaling research.
10 mg
View details →